(Q38361993)

2 September 2017

1 reference

title

Pharmacokinetic-pharmacodynamic relationships of Acarbose (English)

1 reference

ORCID Public Data File 2021

2 September 2017

1 reference

1 reference

1 reference

author name string

Salvatore T

series ordinal

1

1 reference

PubMed ID

8906894

2 September 2017

Giugliano D

series ordinal

2

1 reference

2 September 2017

1 February 1996

1 reference

Clinical Pharmacokinetics

2 September 2017

1 reference

2 September 2017

30

1 reference

2 September 2017

2

1 reference

2 September 2017

94-106

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199630020-00002

2 September 2017

0 references

cites work

[Inhibitors of alpha-glucosidase]

1 reference

12 December 2020

Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus

1 reference

12 December 2020

Acarbose in reactive hypoglycemia: a double-blind study

1 reference

12 December 2020

Increased activity of rat intestinal lactase due to increased intake of alpha-saccharides (starch, sucrose) in isocaloric diets

1 reference

12 December 2020

Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption

1 reference

12 December 2020

Nutritional Recommendations for Diabetic Patients and Treatment with α-Glucosidase Inhibitors

1 reference

12 December 2020

Influence of an ??-amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and nefa in starch loading tests in rats, dogs and man

1 reference

12 December 2020

Combined use of guar and acarbose in reduction of postprandial glycaemia

1 reference

12 December 2020

Effects of an α-Glucosidase Inhibitor, Acarbose, on Blood Glucose and Serum Lipids in Streptozotocin-Induced Diabetic Rats

1 reference

12 December 2020

Effects of acarbose on serum lipoproteins in healthy individuals during prolonged administration of a fiber-free formula diet

1 reference

12 December 2020

Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor

1 reference

12 December 2020

The use of acarbose in the prevention and treatment of hypoglycaemia.

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice

1 reference

12 December 2020

Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors

1 reference

12 December 2020

Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics

1 reference

12 December 2020

Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency

1 reference

12 December 2020

Double-blind Crossover Study of Acarbose in Type 1 Diabetic Patients

1 reference

12 December 2020

alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial origin

1 reference

12 December 2020

Intestinal effects of alpha-glucosidase inhibitors: absorption of nutrients and enterohormonal changes

1 reference

12 December 2020

Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study

1 reference

12 December 2020

Influence of acarbose (a glucosidase inhibitor) on experimental atherosclerosis in the rabbit

1 reference

12 December 2020

A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes

1 reference

12 December 2020

A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition

1 reference

12 December 2020

Inhibition of human intestinalα-glucosidehydrolases by a new complex oligosaccharide

1 reference

12 December 2020

Time- and dose-dependency of intestinal lactase activity in adult rat on starch intake

1 reference

12 December 2020

The effect of starch malabsorption on fecal short-chain fatty acid excretion in man

1 reference

12 December 2020

Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

1 reference

12 December 2020

Effect of the?? glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics

1 reference

12 December 2020

alpha-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects.

1 reference

12 December 2020

Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man.

1 reference

12 December 2020

Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats.

1 reference

12 December 2020

alpha-Glucosidase inhibitors in diabetes: lessons from animal studies

1 reference

12 December 2020

Distribution of disaccharidase activity in the small bowel of normal and lactase-deficient subjects

1 reference

12 December 2020

Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose

1 reference

12 December 2020

Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man

1 reference

12 December 2020

Pharmacokinetics of acarbose. Part II: Distribution to and elimination from tissues and organs following single or repeated administration of [14C]acarbose to rats and dogs

1 reference

12 December 2020

Beneficial effects on serum lipids in noninsulin dependent diabetics by acarbose treatment

1 reference

12 December 2020

Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion

1 reference

12 December 2020

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man

1 reference

12 December 2020

Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. American Diabetes Association

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

The roles of alpha-glucosidase inhibitors in diabetes

1 reference

12 December 2020

Effect of acarbose on glucose and insulin response to sucrose load in reactive hypoglycemia

1 reference

12 December 2020

Effect of alpha-glucosidase inhibitor on human pancreatic and salivary alpha-amylase

1 reference

12 December 2020

Acarbose and insulin therapy in type I diabetes mellitus

1 reference

12 December 2020

Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia

1 reference

12 December 2020

10.2165/00003088-199630020-00002

Identifiers

DOI

1 reference

PubMed ID

8906894

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

8906894